Thursday, 11 October 2018

Abbvie settles Humira patent disputes with Novartis unit

Abbvie Inc said on Thursday it settled all patent disputes with Novartis AG, granting it a non-exclusive license to manufacture and sell a copycat version of blockbuster drug, Humira.


No comments:

Post a Comment